Doctors test 'Chemo Spray' to fight advanced stomach cancers
NCT ID NCT07487168
Summary
This early-phase study is testing a new way to deliver chemotherapy directly into the abdomen for people with advanced gastrointestinal cancer that has spread to the abdominal lining. Researchers will spray a chemotherapy drug (mitomycin C) as a fine mist during a minimally invasive procedure to see if it's safe and to find the best dose. The goal is to see if this approach can help control the cancer in patients who are not candidates for major surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERITONEAL CARCINOMATOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Moffitt Cancer Center
Tampa, Florida, 33612, United States
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Conditions
Explore the condition pages connected to this study.